DGS Capital Management’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
DGS Capital Management's CVAC Position: Q1 2026 in Review
DGS Capital Management sold out of CureVac (CVAC) in Q1 2026, closing a stake of 18,036 shares — an estimated $81.5K sold.
DGS Capital Management first reported a position in CVAC in Q4 2025 and held it in 1 quarter. The position peaked at $81.5K in Q4 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- DGS Capital Management reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- DGS Capital Management sold 18,036 CureVac shares in Q1 2026, an estimated $81.5K.
- DGS Capital Management first reported a position in CureVac in Q4 2025 and held it in 1 quarter.
- DGS Capital Management's CureVac position peaked at $81.5K in Q4 2025.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.